Adjuvant chemotherapy in the node-negative breast cancer patient

The Surgical Clinics of North America
T M Styblo, W C Wood

Abstract

For node-negative patients with tumors 2 cm or greater, the advantage of adjuvant therapy seems to outweigh any associated morbidity. For women less than 50, polychemotherapy (CMF, CA, CAF) is the standard of care. For women older than 50 who are hormone receptor positive, tamoxifen provides the major benefit. For estrogen receptor-positive women less than 50, adding tamoxifen and for estrogen receptor-positive women older than 50, adding chemotherapy may provide smaller incremental benefit. For hormone receptor-negative women over 50 years, there is a lesser but real benefit from polychemotherapy and a small benefit from tamoxifen (perhaps because of false receptor-negative results.) For tumors 1 cm or less in size (or tubular, papillary < 2 cm), the prognosis is so favorable that outside a clinical trial, adjuvant therapy is not recommended. For patients with node-negative tumors 1 to 2 cm in size, other prognostic factors, size (1.1 versus 1.9 cm), possibility of tamoxifen benefit, and age (45 versus 80 years) all influence the physician's recommendation to the patient.

References

Jun 20, 1990·Journal of the National Cancer Institute·W L McGuireG M Clark
Feb 23, 1989·The New England Journal of Medicine·E G MansourG Falkson
Jan 13, 1984·Biochemical and Biophysical Research Communications·H Y Lam
May 5, 1994·The New England Journal of Medicine·W C WoodC R Ferree

❮ Previous
Next ❯

Citations

Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Pauline T TruongIvo A Olivotto
Feb 1, 2004·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Nam Yong DoSung Chul Lim
Oct 4, 2003·ANZ Journal of Surgery·David S WilkinsonIan C Bennett
Jul 8, 2010·Theoretical Medicine and Bioethics·Marya Schechtman
Jun 11, 2005·Cancer Investigation·Donna L SkerrettLinda Vahdat
Sep 9, 1999·Journal of Surgical Oncology·C S Kaufman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.